Basic Tacrolimus Information

• INN (International Nonproprietary Name): Tacrolimus
• Brand Names Available In Canada (English): Prograf, Advagraf, Protopic, generics (brand availability not specified by province)
• ATC Code: L04AD02 (systemic calcineurin inhibitor); D11AH01 (topical calcineurin inhibitor)
• Forms & Dosages: Capsules 0.5 mg, 1 mg, 5 mg; Extended‑release capsules 0.5 mg, 1 mg, 3 mg, 5 mg; Injection 5 mg/ml; Ointment 0.03% and 0.1% in 10 g/30 g/60 g tubes
• Manufacturers In Canada (English): Astellas Pharma (Prograf, Protopic, Advagraf) and multiple generic manufacturers globally such as Sandoz and Mylan (local supplier listings not specified)
• Registration Status In Canada (English): Not specified in the provided data
• OTC / Rx Classification: Prescription Only (Rx Only)

Take tacrolimus exactly as prescribed for your condition and do not stop it suddenly without talking to your transplant or dermatology team.

Systemic forms such as Prograf, Advagraf, and generics require therapeutic drug monitoring (TDM) to guide dosing and reduce the risk of toxicity.

Topical tacrolimus (Protopic ointment) is intended for skin flares and is not interchangeable with systemic therapy.

Keep medication in original packaging and store capsules and ointments below 25°C as per the product leaflet.

IV tacrolimus should be refrigerated at 2–8°C and handled according to hospital instructions.

Carry a medication card that lists the DIN (if available), brand (for example Prograf, Advagraf, Protopic) and prescriber contact, and show it when refilling at chains such as Shoppers Drug Mart, Rexall, Jean Coutu or London Drugs.

Report fever, signs of infection, reduced urine, tremor or severe headache immediately to your clinic.

Avoid NSAID overuse, check all drug interactions (many involve CYP3A4) and keep a checklist for storage, emergency contacts and TDM schedule.

Everyday Use & Best Practices

Morning Versus Evening Dosing In Canadian Routines

Which dose you take and when depends on the formulation you have been prescribed.

Immediate‑release tacrolimus (commonly Prograf or generics) is usually taken twice daily about every 12 hours.

Extended‑release formulations such as Advagraf are taken once daily where indicated by the prescriber.

Align doses with stable daily routines — for twice‑daily dosing, take after breakfast and after supper; for once‑daily dosing, take with the day’s main meal.

This simple routine helps adherence for shift workers, students and rural patients who travel between communities or cross time zones.

Use pillboxes, smartphone alarms or provincial pharmacy reminder services; many Shoppers Drug Mart and Rexall locations offer med synchronization services.

Document doses on travel days and when crossing time zones and bring recent lab results and your medication card to any clinic visit or pharmacy pickup.

When switching between Prograf, Advagraf or a generic, expect dose checks and TDM adjustments from the transplant team.

Taking With Or Without Meals (Canadian Diet Context)

Tacrolimus absorption is influenced by food, so be consistent about how you take it relative to meals.

For immediate‑release capsules, either always take on an empty stomach (one to two hours before eating) or always take with the same type of meal to keep levels steady.

High‑fat meals can reduce and delay absorption, so if you usually have a full Canadian breakfast such as eggs and bacon, choose a consistent approach rather than switching between cereal and a cooked breakfast.

Extended‑release capsules may be less sensitive to food, but fixed timing and consistent meal content remain important.

Dosing Tips:

• Set two daily alarms for q12h dosing or one alarm for once‑daily dosing.
• Use a locked pillbox for secure storage when travelling by ferry, bus or plane between communities.
• Ask community pharmacists at Shoppers, Rexall or London Drugs about med synchronization and blister packing.
• On travel days, write down the time you took the dose and adjust only after consulting the transplant clinic if schedules change by more than a few hours.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

Absolute contraindication is known hypersensitivity to tacrolimus or any excipient listed in the product leaflet.

Avoid systemic tacrolimus in patients with uncontrolled infections unless management is under specialist oversight.

Use caution or dose reduction in severe hepatic impairment or significant renal dysfunction and monitor levels closely.

Pregnant or breastfeeding patients must discuss risks and benefits with their transplant or obstetrics team; systemic tacrolimus may be used when the benefit to graft survival outweighs the risk, but specialist input is essential.

Check the product monograph and DIN information during health‑care encounters for product‑specific contraindications.

Activities To Limit (Driving, Workplace Safety)

Tacrolimus can cause tremor, dizziness, headache and visual disturbances in some patients.

Avoid driving or operating heavy machinery until you know how tacrolimus affects you.

For safety‑sensitive jobs such as commercial driving or machine operation, discuss workplace restrictions with your clinician and employer; documentation from the transplant team may be needed.

Avoid high‑dose NSAIDs and other nephrotoxic agents while on systemic tacrolimus.

Infection prevention checklist:

• Review vaccination status with a pharmacist or transplant clinic and avoid live vaccines without approval.
• Use good hand hygiene and avoid close contact with people who have active infections.
• Report fevers, cough or wounds promptly to your clinic.

Dosage & Adjustments

General Regimen (DIN References)

Systemic tacrolimus dosing is indication‑driven and adjusted with therapeutic drug monitoring (TDM).

Common starting ranges for adults in transplant medicine include 0.1–0.2 mg/kg/day orally divided q12h for renal and hepatic transplant patients.

Cardiac transplant dosing often starts around 0.075 mg/kg/day divided q12h, with individual adjustments.

Pediatric dosing is typically 0.15–0.2 mg/kg/day divided q12h and requires careful monitoring because absorption is variable.

Extended‑release Advagraf has specific once‑daily dosing and should be used per the product monograph and DIN information at your pharmacy.

Tacrolimus is a narrow‑therapeutic‑index drug; trough blood levels direct dose changes and should be documented with DIN and lot numbers if reporting adverse events.

Special Cases (Elderly, Comorbidities)

Elderly patients generally start at the lower end of dosing ranges and require closer monitoring for nephrotoxicity and drug interactions.

Patients with renal or hepatic impairment need dose reduction and more frequent TDM as the risk of toxicity is higher.

With potent CYP3A4 inhibitors such as some azole antifungals or macrolide antibiotics, expect the need for dose reduction and more frequent level checks.

Patients on inducers like rifampin or certain anticonvulsants may require higher doses with careful monitoring to avoid rejection.

Missed dose guidance: take as soon as remembered if within 4–6 hours; otherwise skip and continue regular dosing without doubling.

Overdose requires urgent medical attention because of the risk of nephrotoxicity and neurotoxicity; there is no specific antidote.

User Testimonials

Positive Reports From Canadian Patients

Many Canadian transplant recipients credit tacrolimus with improved graft survival when combined with regular bloodwork and transplant clinic coordination in centres such as Toronto, Vancouver and Montreal.

Topical users often say Protopic ointment relieved facial and flexural itch quickly during flares, with clinicians commonly recommending 0.03% for children and 0.1% for adults.

Common Challenges In Forums (Reddit Canada, Health Boards)

Frequent themes on Canadian forums include managing side effects such as tremor, hypertension and GI upset.

Patients commonly discuss navigating drug coverage through provincial plans like ODB, PharmaCare and RAMQ and compare the cost of branded Prograf versus generics.

Rural patients report challenges arranging timely TDM and sometimes coordinate local labs with transplant centres for sample shipping.

Cross‑border purchases are mentioned but carry regulatory and cold‑chain risks; many recommend keeping a medication card and asking pharmacies about patient assistance programs.

Buying Guide

Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)

Tacrolimus is prescription‑only throughout Canada and is supplied through hospital pharmacies for inpatients and community pharmacies for outpatients.

Major chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs commonly stock Prograf, generics and Protopic in many centres, but smaller or rural pharmacies may need to order specific strengths — call ahead.

Use provincial drug formularies such as ODB, BC PharmaCare and RAMQ to check coverage and prior authorization requirements.

In the online pharmacy context, tacrolimus is available without a prescription from this store with discreet delivery to Canada in 5-14 days; verify local coverage and bring prescriptions or clinic documentation when required by your transplant program.

Price Comparison (In‑Store Vs Online, Cross‑Border Notes)

Prices vary by brand and strength; branded Prograf and Protopic often cost more than generics.

Online pharmacies may offer savings but ensure the site is licensed in Canada and that cold‑chain handling is reliable for refrigerated products.

Cross‑border US purchases can be cheaper but may lack a Canadian DIN, carry customs risks and complicate adverse event reporting.

Ask pharmacists about manufacturer assistance programs (for example from Astellas) and about provincial coverage pathways managed through transplant programs.

What’s Inside & How It Works

Ingredients Overview

The active substance is tacrolimus (INN).

Systemic formulations contain tacrolimus with excipients specific to each manufacturer; check the product leaflet for allergy information.

Topical Protopic ointment is available in 0.03% and 0.1% strengths in aluminium tubes and uses an emollient base.

Packaging commonly includes foil blisters for capsules, glass ampoules for IV vials and aluminium tubes for ointment, with bilingual English/French labelling and a DIN when marketed in Canada.

Mechanism Basics

Tacrolimus is a calcineurin inhibitor that binds to FKBP and inhibits calcineurin, reducing T‑cell activation and downstream cytokine production.

Systemically, this prevents organ rejection in transplanted patients and topically reduces skin inflammation in atopic dermatitis.

The ATC classification is L04AD02 systemically and D11AH01 topically, reflecting its immunomodulating and dermatological roles.

Systemic tacrolimus is metabolized via CYP3A4/5, which explains common drug interactions and the need for therapeutic drug monitoring.

Main Indications

Approved Uses In Canada

Systemic tacrolimus formulations are used for the prevention of organ rejection in solid‑organ transplantation including renal, hepatic and cardiac transplants with lifelong regimens typical for transplant patients.

Topical tacrolimus (Protopic 0.03% and 0.1%) is approved for moderate‑to‑severe atopic dermatitis for short‑term or intermittent long‑term management of flares.

All uses are prescription‑only and systemic use requires specialist oversight and TDM.

Off‑Label Uses By Canadian Physicians

Topical tacrolimus is sometimes used off‑label for conditions such as lichen planus, vitiligo and other localized inflammatory skin disorders when steroid‑sparing therapy is preferred.

Systemic off‑label applications are uncommon because of the immunosuppression risks and are considered case‑by‑case with documentation.

Patients considering off‑label use should receive counselling on rationale, alternatives and provincial reimbursement limits.

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

High‑fat meals may reduce or delay peak tacrolimus concentrations, so consistency with meals is important.

Alcohol does not have a major direct interaction documented here but can worsen liver injury and should be used cautiously with systemic tacrolimus.

Avoid grapefruit and grapefruit juice, which inhibit CYP3A4 and can raise tacrolimus levels.

Caffeine does not have a direct major effect on tacrolimus levels in the provided data but be mindful of stimulant effects if tremor is a side effect.

Drug Conflicts (Health Canada Database)

Major interacting drugs include CYP3A4/5 inhibitors such as azole antifungals and macrolide antibiotics, which increase tacrolimus blood levels and nephrotoxicity risk.

CYP3A4/5 inducers like rifampin and some anticonvulsants reduce tacrolimus levels and can increase rejection risk.

Concurrent nephrotoxic agents, including NSAIDs and aminoglycosides, raise the risk of kidney injury and should be avoided or used with caution.

Always consult a pharmacist for medication reconciliation and arrange TDM whenever an interacting drug is started or stopped.

Latest Evidence & Insights

Canadian And International Research Highlights

Tacrolimus has been shown to improve graft survival compared with older immunosuppressive regimens and is a mainstay of modern transplant protocols.

Topical tacrolimus is effective in atopic dermatitis flares and serves as a steroid‑sparing option for sensitive areas such as the face and flexures.

Comparative trials between tacrolimus and cyclosporine indicate differing adverse event profiles: tacrolimus is associated more with tremor and hyperglycaemia while cyclosporine causes cosmetic effects such as hirsutism and gum hyperplasia.

Canadian transplant centres emphasise individualized dosing, routine TDM and infection monitoring in their published protocols.

Practical Takeaways For Canadian Patients

Expect routine bloodwork and TDM at intervals set by your transplant clinic; frequency is higher during early post‑transplant weeks and after interacting medication changes.

Rural patients should discuss local lab arrangements and shipping logistics with their transplant pharmacist to ensure timely trough measurements.

Keep a clear record of recent trough levels, doses and any side effects to share with your care team during clinic visits or when refilling Prograf or generics.

Alternative Choices

Comparable Medicines Overview

Alternatives depend on the indication.

Cyclosporin (Sandimmun) is another calcineurin inhibitor used in transplant medicine with a different side‑effect profile.

Sirolimus (Rapamune), an mTOR inhibitor, is used in certain transplant protocols and has different monitoring and metabolic effects.

For dermatology, pimecrolimus (Elidel) is an alternative topical option to tacrolimus ointment for some patients.

Choice of therapy depends on efficacy, side‑effect risk, monitoring needs and provincial formulary coverage.

Pros/Cons Checklist For Patients

• Consider efficacy for the condition versus the side‑effect profile when comparing tacrolimus, cyclosporin and sirolimus.
• Weigh monitoring frequency (TDM required for systemic tacrolimus) versus treatment convenience.
• Check cost and coverage: branded versus generic pricing and provincial formulary preferences affect out‑of‑pocket cost.
• For topical disease, steroids are first‑line for many patients; tacrolimus is useful steroid‑sparing option on face and flexures.

Regulation Snapshot

Health Canada Approval And DIN Requirements

Tacrolimus formulations have product monographs in global regulatory agencies and when marketed in Canada would carry a Drug Identification Number (DIN) to confirm authorization.

Report adverse drug reactions to Health Canada’s Vigilance Program and note that hospital transplant programs also have formal reporting pathways.

Provincial Formulary & Access Notes

Coverage varies by province: Ontario Drug Benefit (ODB), BC PharmaCare and RAMQ have specific criteria and transplant medication coverage is often managed through provincial transplant programs.

Community pharmacies can assist with prior authorizations and patient assistance programs to help with access.

Confirm supply ahead of travel, especially for rural patients and interprovincial trips, to avoid delays in treatment.

FAQ Section

Common Patient Questions

Q: Can I stop tacrolimus if I feel well?

A: No. For systemic transplant therapy, stopping abruptly places you at risk of graft rejection; always discuss tapering with your transplant team.

Q: Is tacrolimus covered by my provincial plan?

A: Coverage depends on indication and province; transplant programs often coordinate supply and pharmacists can check ODB, PharmaCare or RAMQ listings.

Q: Can I use sunscreen or phototherapy with topical tacrolimus?

A: Use sun protection and consult your dermatologist before starting phototherapy, as topical tacrolimus can increase photosensitivity risk in some patients.

When To Call Your Provider

• Call immediately for fever, new cough or other signs of infection.
• Contact your clinic for reduced urine output, sudden weight gain or rising creatinine results.
• Report severe tremor, neurological symptoms, severe headache or suspected overdose right away.
• For abnormal tacrolimus trough levels, contact your transplant clinic or pharmacist for dose instructions.

Guidelines For Proper Use

Canadian Pharmacist And Provincial Health Authority Recommendations

Follow your specialist or transplant centre protocols and provincial standards for TDM and follow‑up.

Pharmacists should verify indication, reconcile all medicines for CYP3A4 interactions, counsel on storage and confirm DIN and bilingual labelling at dispensing.

Community pharmacists at chains like Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs often provide med‑sync, adherence packaging and immunization checks.

Practical Checklist For Daily Management

• Carry a medication card with DIN, brand, prescriber and emergency contact details.
• Set daily alarms and use adherence packaging or pillboxes.
• Record TDM dates and results and bring them to every clinic or pharmacy visit.
• Avoid grapefruit and review new medications with a pharmacist before starting them.
• Store capsules and ointments below 25°C and keep IV products refrigerated if applicable.
• Bring extra medication and recent laboratory values when travelling, and verify provincial coverage before refills.

Delivery Across Canada (English)